Globus Medical, Inc. (FRA:GM0N)
Germany · Delayed Price · Currency is EUR 79.50
-0.50 (-0.63%)
At close: Jan 23, 2026
Globus Medical Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | 423.78 | 102.98 | 122.87 | 190.17 | 149.19 | 102.29 |
Depreciation & Amortization | 275.71 | 254.02 | 144.73 | 68.25 | 69.87 | 62.87 |
Loss (Gain) From Sale of Assets | 11.3 | 5.55 | 1.54 | 0.3 | 0.46 | 0.81 |
Asset Writedown & Restructuring Costs | - | 12.61 | - | 0.15 | 34.31 | 24.42 |
Loss (Gain) From Sale of Investments | -0.99 | -0.64 | 0.79 | 5.39 | 2.78 | 0.59 |
Stock-Based Compensation | 50.27 | 54.19 | 52.74 | 32.81 | 30.59 | 27.07 |
Provision & Write-off of Bad Debts | 6.63 | 16.99 | 3.66 | -0 | 1.2 | 2.96 |
Other Operating Activities | -33.48 | 172.48 | 33.76 | -13.34 | 5.13 | 15.38 |
Change in Accounts Receivable | 34.45 | -78.06 | -49.91 | -50.84 | -25.9 | 10.7 |
Change in Inventory | -29.31 | -29.86 | -70.33 | -61.75 | -11.97 | -50.11 |
Change in Accounts Payable | 15.72 | 17.66 | -14.22 | 14.42 | 3.68 | -6.35 |
Change in Income Taxes | -66.44 | -13.38 | -0.41 | -2.89 | 5.21 | 1.66 |
Change in Other Net Operating Assets | 27.55 | 6.08 | 18.28 | -4.21 | 11.72 | 6.52 |
Operating Cash Flow | 715.2 | 520.64 | 243.5 | 178.47 | 276.27 | 198.79 |
Operating Cash Flow Growth | 72.35% | 113.81% | 36.44% | -35.40% | 38.98% | 15.59% |
Capital Expenditures | -135.59 | -115.43 | -78.27 | -74.05 | -56.9 | -63.66 |
Cash Acquisitions | -252.55 | -17.64 | -296.03 | -31.44 | -34.49 | -33.48 |
Investment in Securities | 50.12 | -42.99 | 677.27 | -4.88 | -284.55 | -20.18 |
Investing Cash Flow | -347.69 | -176.05 | 302.97 | -110.36 | -375.94 | -117.32 |
Issuance of Common Stock | 96.28 | 110.44 | 12.4 | 41.72 | 63.5 | 72.32 |
Repurchase of Common Stock | -259.08 | -92.52 | -236.18 | -144.49 | - | -104.67 |
Other Financing Activities | -19.86 | -45.62 | -8.04 | -7.19 | -9.35 | -6.32 |
Financing Cash Flow | -632.64 | -27.7 | -231.82 | -109.96 | 54.15 | -38.66 |
Foreign Exchange Rate Adjustments | 14.13 | 0.26 | 2.18 | -0.75 | -0.81 | 0.87 |
Net Cash Flow | -251 | 317.15 | 316.83 | -42.6 | -46.33 | 43.67 |
Free Cash Flow | 579.61 | 405.21 | 165.23 | 104.42 | 219.38 | 135.14 |
Free Cash Flow Growth | 97.30% | 145.25% | 58.23% | -52.40% | 62.34% | 33.50% |
Free Cash Flow Margin | 20.93% | 16.08% | 10.53% | 10.21% | 22.90% | 17.13% |
Free Cash Flow Per Share | 4.21 | 2.94 | 1.44 | 1.02 | 2.12 | 1.34 |
Cash Income Tax Paid | 136.13 | 158.51 | 100.59 | 77.82 | 45.03 | 25.44 |
Levered Free Cash Flow | 445.76 | 598.37 | -346.92 | 75.52 | 160.53 | 88.28 |
Unlevered Free Cash Flow | 445.76 | 600.98 | -346.92 | 75.52 | 160.53 | 88.28 |
Change in Working Capital | -18.02 | -97.55 | -116.6 | -105.26 | -17.25 | -37.59 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.